Tag: drug lifecycle management

Pediatric Exclusivity: How FDA Extends Patent Protection by 6 Months

Learn how pediatric exclusivity under FDA Section 505A adds six months of market protection without extending patent terms. Understand the rules, scope, and strategic value for drug lifecycle management.

Learn More